Capricor reports positive HOPE-3 trial results for Duchenne therapy
Go back to Capricor reports positive HOPE-3 trial results for Duchenne therapy| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 29.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.51 | 52 Week High | $5.40 | |||
| Open | $29.51 | 52 Week Low | $1.88 | |||
| Day High | $29.51 | P/E | N/A | |||
| Day Low | $29.51 | EPS | $0.00 | |||
| Volume | 140 | |||||
